Short terms surgical outcome of Endoscopic transforaminal lumbar interbody fusion versus Microtubular transforaminal lumbar interbody fusion in degenerative lumbar spine Disease

Recruiting

• Conditions: Degenerative spine disease those need 1 or 2 level fusion; Degenerative spine disease, Fail conservative

• Registration Number: TCTR20230425004
• Lead Sponsor: Thammasat university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-04-25
• Study Completion: 2024-04-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 62

Inclusion Criteria

Aged 18 and 75 years
Degenerative spine disease those need 1 or 2 level fusion:
Degenerative disc disease
low-grade spondylolisthesis
spinal stenosis
spondylosis, degenerative scoliosis
Understand the protocol and volunteers to join study

Exclusion Criteria

Revision TLIF
High-grade spondylolisthesis(grade >2)
Other spinal diseases
(eg, spine infection,ankylosing spondylitis, tumor, trauma, etc. )
Cognitive and psychological disorders

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Post operation pain at 12 months after end of the intervention VAS score

Secondary Outcome Measures

Name	Time	Method
Functional outcome at 12 months after end of the intervention ODI score